Number of pages: 100 | Report Format: PDF | Published date: March 16, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
According to the deep-dive market assessment study by Growth Plus Reports, the global patient warming market was valued at US$ 1.57 billion in 2022 and is expected to register a revenue CAGR of 7.5% to reach US$ 2.98 billion by 2031.
Patient Warming Market Fundamentals
During operations and intra-hospital patient transfers, healthcare providers employ patient warming equipment. These patient warming devices have been helpful in circumstances where severely injured patients may suffer or die from hypothermia. Rewarming is crucial to prevent complications after large surgeries, such as cardiovascular and other types of surgery, since physiological temperature frequently lowers during these procedures. By halting any sudden body heat loss, patient warming devices can aid in maintaining normothermia, resulting in a quicker recovery. Catheters, temperature gauges, and cooling jackets are examples of patient-warming equipment. A catheter administers hot intravenous fluid to prevent tissue injury while keeping temperatures between 50°C and 100°C. The catheter is wrapped by a cooling jacket that transports unheated fluid between the gaps to prevent any substantial entry site and endothelial damage from the hot fluid. Devices for warming patients can significantly reduce the risk of post-operative wound infection, myocardial infarctions, mortality rates, and length of stay in the intensive care unit.
Patient Warming Market Dynamics
As the number of surgeries being conducted worldwide grows, so does the demand for patient warming devices to maintain patient body temperature during procedures. The growing number of surgeries is related to the growth in dialysis adoption in severe stages of a medical patient and disease complexity. According to the American Kidney Fund’s 2022 revised statistics, over 37 million Americans have renal disease, and as of 2021, it was predicted that 810,000 of them had kidney failure. As a result, the adoption of dialysis machines fuels the demand for patient warming. The prevalence of hypothermia, especially among surgical patients, increases the need for patient warming devices to prevent complications and promote faster recovery times. Innovations in patient warming device design and technology make them more effective, user-friendly, and customizable, driving global market revenue growth. As healthcare professionals become more aware of the benefits of patient warming devices, they are increasingly adopted in hospitals, clinics, and other medical facilities. With an aging global population, the need for surgical interventions and treatments for age-related diseases has increased, driving demand for patient warming devices. Initiatives by governments and healthcare organizations to create awareness about the importance of maintaining patient temperature during surgery contribute to market revenue growth. As home healthcare services become more popular, the need for patient warming devices to ensure patient comfort and safety during at-home medical procedures and treatments also grows.
However, a few factors are restraining the growth of the global patient warming market. The high cost of advanced warming devices may limit their adoption in healthcare facilities with budget constraints, especially in developing regions. Additionally, risks associated with overheating, skin burns, and patient discomfort may negatively impact the global patient warming market revenue growth.
Patient Warming Market Ecosystem
The global patient warming market has been analyzed from three perspectives: product, application, and region.
Patient Warming Market by Product
Based on product, the global patient warming market has been segmented into intravenous warming systems, surface warming systems, and patient warming accessories.
The intravenous warming system segment accounts for the largest revenue share in the global patient warming market. Using intravenous warming systems can greatly reduce unintentional perioperative hypothermia (IPH) during surgical procedures. Patient warming devices are designed to supply fluid around body temperature (37 °C), and their usage has been suggested for all intraoperative infusions. The high revenue growth rate of the segment is attributable to the rise in surgical procedures, primarily due to the increased incidence of severe chronic diseases and other conditions that affect the kidneys during long-term illnesses.
The World Health Organization (WHO) estimated that 15 million babies will be born prematurely in 2021, increasing the need for patient-warming equipment in hospitals and clinics. According to data from the 2020 report by WHO, road traffic injuries put the lives of over 1.35 million individuals at risk each year. Between 20 and 50 million people worldwide experience non-fatal injuries, many of which leave them disabled. These accidents and emergencies result in surgeries, fueling the global patient warming market revenue growth. Therefore, the intravenous warming system is anticipated to substantially expand throughout the projection period due to the considerations above.
The surface patient warming systems segment is projected to grow with a high revenue CAGR in the global patient warming market. This is because they are frequently used in procedures that involve general anesthesia. The general anesthetic administered before surgery lowers the patient’s body temperature. Thus, it is necessary to pre-warm the patient’s body before surgery to lower the risk of perioperative hypothermia.
Patient Warming Market by Application
Based on application, the global patient warming market has been segmented into perioperative care, neonatal care, and acute care.
The perioperative care segment accounts for the largest global patient warming market revenue share. Patients’ body temperatures drop during surgery due to anesthesia, which is the main cause of IPH, which must be treated immediately. The American Society of Anesthesiologists (ASA) claims that thorough perioperative temperature control within the normothermic range can ensure satisfactory surgical outcomes. Furthermore, according to ASA, almost 50% of surgical patients in the United States have IPH, which can be treated with patient warming devices, which is driving the revenue growth of the global patient warming market.
The neonatal care segment is projected to grow at a high revenue CAGR in the global patient warming market. A crucial component of neonatal care is newborn warming, especially for premature infants or infants with low birth weight. Maintaining a healthy body temperature is essential to prevent hypothermia, which can result in consequences, such as respiratory distress, hypoglycemia, and even death.
Patient Warming Market by Region
Based on region, the global patient warming market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounts for the largest global patient warming market revenue share. Over the projected period, the United States is anticipated to play a significant role in the revenue growth of the patient warming market. The United States Government invests much of its GDP in healthcare each year. The primary drivers of the market revenue growth under study are an increase in surgeries and the prevalence of chronic diseases. The nation also has a high rate of visits to emergency rooms. The Centers for Disease Control and Prevention (CDC) reported that 16.2 million visits to emergency rooms resulted in hospital admissions in 2021. About 2.3 million of them needed to be admitted to critical care facilities. Patient warmer devices will become more popular in the country due to the frequent emergency transfusions that these serious cases necessitate to keep patients from hypothermia. Also, compared to other industrialized nations, the United States has a greater rate of preterm births. According to the CDC, one in ten newborns born in the United States yearly is preterm.
The patient warming market in Europe is expected to grow steadily in the coming years due to an increasing number of surgeries, an aging population, and a rising incidence of hypothermia. Patient warming devices are used to maintain a patient’s body temperature during surgery and in post-operative care to prevent complications and improve recovery times. Some key players in the Europe patient warming market include 3M Healthcare, Smiths Medical, Stryker Corporation, and Covidien. The market is highly competitive, with companies focusing on product innovation and technological advancements to gain a competitive edge. In addition, the Europe market is highly regulated, with strict standards and regulations to ensure patient safety. The EU Medical Devices Regulation, which came into effect in May 2021, has further strengthened the regulatory environment and increased scrutiny of medical device manufacturers.
The patient warming devices market in Asia Pacific is projected to grow at a higher revenue CAGR during the forecast period. An aging population, an increase in surgeries, and improvements in medical technology are driving the revenue growth of the patient warming market. Key players in the market include 3M, Smiths Medical, Geratherm Medical, and ZOLL Medical Corporation. The market is expected to witness increased demand for air-warming systems, water-warming systems, and intravenous fluid-warming devices.
The prominent players operating in the global patient warming market are:
The global patient warming market is expected to grow at a revenue CAGR of 7.5% during the forecast period.
3 M Company, GE Healthcare, Geratherm Medical, Smith’s Group Plc., Stryker Corporation, and Medtronic Plc are among the key players in the global patient warming market.
The intravenous warming segment accounts for the largest revenue share in the global patient warming market.
An increasing number of surgeries and trauma cases are contributing to the revenue growth of the global patient warming market.
The global patient warming market was valued at US$ 1.57 billion in 2022.
*Insights on financial performance are subject to the availability of information in the public domain